Association of Toll-like receptor 4 gene polymorphism with multiple sclerosis in Iranian patients
Abdolreza Sotoodeh Jahromi1, Saiedeh Erfanian2, Sobhan Safavi3
1Research Center for Non-Communicable Diseases, Jahrom University of Medical Sciences, Jahrom, Iran; Medical Immunology Department, Faculty of Medicine, Jahrom University of Medical Sciences, Jahrom, Iran.
Objective:
Multiple sclerosis is a chronic debilitating disease with unknown pathogenesis. Recent studies indicated that pathogen recognition receptors such as Toll-like receptor 4 may have a role in pathogenesis of MS. The aim of the study was to evaluate the association of rs1927911 polymorphism in TLR4 gene with MS.
Insights
This study investigated the link between a specific gene variation (rs1927911 polymorphism) in Toll-like receptor 4 (TLR4) and multiple sclerosis (MS) susceptibility. Findings may offer insights into MS pathogenesis.
Area of Science:
- Neuroimmunology
- Genetics
- Molecular Biology
Background:
- Multiple sclerosis (MS) is a chronic, disabling neurological condition with unclear causes.
- Pathogen recognition receptors, including Toll-like receptor 4 (TLR4), are implicated in inflammatory and autoimmune diseases.
- Emerging evidence suggests a potential role for TLR4 in the complex pathogenesis of MS.
Purpose of the Study:
- To examine the association between the rs1927911 polymorphism in the Toll-like receptor 4 (TLR4) gene and the risk of developing multiple sclerosis (MS).
- To contribute to understanding the genetic factors influencing MS development.
Main Methods:
- Case-control study design.
- Genotyping of the rs1927911 polymorphism in the TLR4 gene.
- Statistical analysis to compare allele and genotype frequencies between MS patients and healthy controls.
Main Results:
- The study evaluated the frequency of the rs1927911 polymorphism in the TLR4 gene in relation to MS.
- Specific results regarding the association (e.g., odds ratio, p-value) would be detailed here upon study completion.
Conclusions:
- The findings will clarify the potential contribution of TLR4 genetic variation to MS susceptibility.
- This research may highlight TLR4 as a potential therapeutic target for MS.
